Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Patent
1998-08-03
1999-11-23
Degen, Nancy
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
435352, 435455, 435465, 536 231, 536 234, C12N 500
Patent
active
059899107
ABSTRACT:
The present invention provides a system for controlled transgene transcription using chimeric activator and repressor proteins functioning in a novel regulatory network. The target transgene is actively silenced in non-inducing conditions by a novel class of chimeric proteins consisting of the DNA-binding tetracycline repressor fused to distinct multimerized eukaryotic transcriptional repression domains. In the presence of a tetracycline "inducer", the repressor does not bind to the promoters for both the target gene and for another regulatory gene encoding a transactivator (e.g., GAL4-VP16). Under these inducing conditions, the transactivator activates expression of the target transgene and of its own gene, in an additional autoregulatory positive feedback loop.
REFERENCES:
patent: 5589362 (1996-12-01), Bujard
patent: 5814618 (1998-09-01), Bujard et al.
Aebischer et al., Nature Medicine 2, 696-699 (1996).
Baniahmad et al., EMBO J., 11, 1015-1023 (1992).
Baniahmad et al., Mol. Cell Biol., 15, 76-86 (1995).
Baniahmad et al., Mol. Cell Biol., 17, 4259-4271 (1997).
Deuschle et al., Mol. Cell Biol.. 15, 1907-1914 (1995).
Fisher et al., Mol. Cell Biol., 16, 2670-2677 (1996).
Friedman et al., Genes Dev., 10, 2067-2078 (1996).
Furth et al., Proc. Natl. Acad. Sci., USA, 91, 9302-9306 (1994).
Gossen et al., Proc. Natl. Acad. Sci., 89, 5547-5551 (1992).
Gossen et al., Current Opinion in Biotechnology, 5, 516-520 (1994).
Gossen et al., Science, 268, 1766-1769 (1995).
Grbavec et al., Biochem. Biophys. Res. Com., 223, 701-705 (1996).
Hassig et al., Cell, 89, 341-347 (1997).
Magari et al. J. Clin. Invest., 100, 2865-2872 (1997).
Moosman et al. Nucl. Acids Res., 24, 4859-4867 (1996).
Nagy et al. Cell, 89, 373-380 (1997).
No. et al. Proc. Nat'l. Acd. Sci. USA 93, 3346-3351 (1996).
Palapati et al. J. Biol. Chem., 272, 26604-26610 (1997).
Resnitzky et al. Mol. Cell. Biol. 14, 1669-1679 (1994).
Rivera et al. Nat. Med. 2, 1028 (1996).
Roelant et al. BioTechniques, 20, 914-917 (1996).
Sadowski et al. Nucl. Acids Res. 17, 7539 (1989).
Sadowski et al. Nature, 335, 563-564 (1988).
Smale et al. Cell., 57 103-113 (1989).
Spencer et al. Science, 262, 1019-1024 (1993).
Thompson et al. Gene, 103, 171-177 (1991).
Wang et al. Proc. Nat'l. Acad. Sci. USA, 91, 8180-8184 (1994).
Wang et al. Gene Therapy, 4, 432-441 (1997).
Wang et al. Nature Biotechnology, 15, 239-243 (1997).
Witzgall et al. Proc. Nat'l Acad. Sci. USA, 91, 4514-4518 (1994).
Yin et al Analytical Biochemistry, 235, 195-201 (1996).
Yuh et al. Science, 279, 1896-1902 (1998).
Chatellard Philippe
Imhof Markus O.
Mermod Nicolas
Degen Nancy
Elrifi Ivor R.
Morency Michel
University of Lausanne
Yucel Irem
LandOfFree
Potent genetic switch allowing regulated gene expression in euka does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potent genetic switch allowing regulated gene expression in euka, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potent genetic switch allowing regulated gene expression in euka will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1220790